OBJECTIVE -Recent studies have shown that C-reactive protein (CRP) predicts future risk of diabetes in healthy Caucasians. We determined whether plasma CRP level was elevated in Chinese subjects with impaired glucose tolerance (IGT) and whether CRP level could be used to predict progression to type 2 diabetes or reversion to normal glucose tolerance (NGT) in these high-risk individuals.
R
ecent studies have suggested that low-grade chronic inflammation may be involved in the pathogenesis of type 2 diabetes. Inflammatory markers such as high white blood cell count, high fibrinogen level, and C-reactive protein (CRP) level have been related to the development of type 2 diabetes. A number of studies have shown that plasma CRP level predicts the development of type 2 diabetes in middle-aged Caucasian men and women and in elderly subjects (1) (2) (3) (4) (5) . A positive association between markers of acute-phase response and features of the insulin resistance syndrome has also been reported (6 -8) . Plasma CRP concentration is increased in patients with impaired glucose tolerance (IGT) and in newly detected type 2 diabetic patients compared with subjects with normal glucose tolerance (NGT), and the increase in inflammatory parameters is parallel to the stages of glucose intolerance (9 -11) . Recent data from Japan have shown that other inflammatory markers may also be a useful predictor in Asian subjects, and a strong association between white blood cell count and features of the metabolic syndrome has been reported in Japanese middle-aged men (12, 13) . The objectives of the present study are, first, to determine whether plasma CRP level is elevated in Chinese subjects with IGT because Chinese individuals, even in those with IGT, are generally less obese than Caucasians (14) , and second, to determine whether plasma CRP level can be used to predict those individuals with IGT who will progress to type 2 diabetes or revert to NGT.
RESEARCH DESIGN AND METHODS -The Hong Kong Cardiovascular Risk Factors Prevalence
Study is a population-based study of diabetes and cardiovascular risk factors (14) . During 1995-1996, 2,900 subjects aged 25-74 years were recruited and all subjects without a history of diabetes underwent a 75-g oral glucose tolerance test (OGTT). A total of 434 subjects with IGT were identified and were subsequently invited to participate in a prospective study on the natural history of IGT in our community (15) . A total of 322 subjects returned for a repeat OGTT at 2 years, and World Health Organization (WHO) 1999 criteria were used to define IGT and diabetes (16) . Only subjects with stored baseline plasma samples available for measurement of CRP (n ϭ 228) were included in the present study. The baseline demographic characteristics of the 228 subjects with IGT did not differ from those subjects with IGT who were excluded from the analysis. Plasma CRP was also measured in baseline samples from 228 subjects with NGT who were matched for age and BMI to establish a normal range.
Fasting plasma glucose and 2-h glucose levels were measured by hexokinase method on a Hitachi 747 analyzer (Boehringer Mannheim, Mannheim, Germany). Insulin was measured by microparticle enzyme immunoassay (MEIA; Abbott Laboratories, Tokyo, Japan). Homeostasis model assessment index was calculated to estimate insulin resistance (HOMA-IR ϭ fasting glucose ϫ fasting insulin/22.5). Plasma total cholesterol and triglyceride levels were determined enzymatically on a Hitachi 717 analyzer (Boehringer Mannheim). HDL cholesterol was measured by the same method after precipitation of apolipoprotein B (apoB)-containing lipoproteins with PEG 6000. LDL cholesterol was calculated using the Friedewald equation. Apolipoprotein AI and apoB were measured by rate nephelometry using the Beckman Array System (Beckman Coulter Instruments, Galway, Ireland). Plasma high-sensitivity CRP was measured using a particle-enhanced immunoturbidimetric assay (Roche Diagnostics, Mannheim, Germany) using anti-CRP mouse monoclonal antibodies coupled to latex microparticles. The assay was standardized against the CRM 470 Reference Preparation for Proteins in Human (RPPHS), with a functional sensitivity of 0.1 mg/l. The intra-assay coefficients of variation were 1.83% at 0.60 mg/l, 2.13% at 6.42 mg/l, and 0.49% at 19.38 mg/l; and interassay coefficients of variation were 7.01% at 0.58 mg/l, 2.55% at 6.39 mg/l, and 2.64% at 18.78 mg/l.
Results are expressed as means and SDs or as medians and interquartile ranges if the distribution of the data was found to be skewed. Data that were not normally distributed were logarithmically transformed before analyses were made. Student's t test and ANOVA were used to analyze continuous variables from two groups and multiple groups, respectively, and proportions were compared using 2 test. Subjects with plasma CRP levels Ͼ15 mg/l (six from the IGT group and four from the NGT group), indicating clinically relevant inflammatory conditions, were excluded from the analysis; none of the six subjects with IGT developed diabetes at 2 years, but four subjects reverted to NGT and two remained IGT. Quartile limits of CRP were determined based on the distribution in subjects with NGT. Quartile-specific risk estimates were obtained in the group of subjects with IGT at baseline using binary logistic regression with glycemic status at 2 years (reversion to NGT versus IGT/incident type 2 diabetes) as the dependent variable. Multinomial logistic regression was performed to determine the predictive power of various biochemical and demographic parameters in determining the progression from IGT to diabetes or reversion to NGT by comparing those two groups against those who remained in IGT at 2 years. The sensitivity and specificity of using various cutoff values of CRP in the prediction of diabetes were examined using the receiver operating characteristic curve analysis.
RESULTS -The baseline characteristics of subjects with NGT and IGT are shown in Table 1 . Despite having similar BMI, waist circumference, and waist-tohip ratio, subjects with IGT still had significantly higher plasma levels of CRP than subjects with NGT. Fasting and 2-h insulin levels were higher in subjects with IGT, and HOMA-IR was also elevated, suggesting that many of these subjects were insulin resistant with hyperinsulinemia.
At 2 years, 117 subjects with IGT had reverted back to NGT, 84 remained in IGT, and 21 had progressed to type 2 diabetes. The baseline clinical and biochemical characteristics based on the category of glucose tolerance by 2 years are shown in Table 2 . Those who reverted back to NGT had lower baseline BMI, waist circumference, and waist-to-hip ratio than those who remained in IGT or progressed to diabetes (Table 2) . They also had the lowest fasting glucose, 2-h glucose, and fasting triglyceride levels as well as systolic blood pressure. There were highly significant differences in plasma CRP levels among the three groups; those who progressed to diabetes had the highest plasma levels.
Plasma CRP levels were divided into quartiles based on the distribution in those 224 subjects with NGT at baseline: quartile 1, median 0. Table 3 . The relative risk according to baseline CRP quartiles before and after adjusting for a number of covariates is shown in Table 4 . Subjects with IGT whose baseline CRP levels were in quartiles 3 and 4 had a relative risk of remaining in IGT or progressing to diabetes of 3.5 and 3.9, respectively. The CRP cutpoint of 0.88 mg/l for quartile 3 has a sensitivity of 100% and specificity of 43% in the prediction of diabetes, whereas the cutpoint of 1.91 mg/l for quartile 4 has a sensitivity of 71% and specificity of 69%.
Multinomial logistic regression was performed to determine the predictive power of baseline parameters in determining progression from IGT to diabetes or reversion to NGT using those who remained in IGT at 2 years as the reference group. Baseline parameters that showed significant differences by 2-year glycemic status were used; results are shown in Table 5 . For progression from IGT to diabetes, 2-h glucose, log(CRP), and sex were significant predictors, whereas for reversion from IGT to NGT, 2-h glucose, BMI, and age were the main predictors.
CONCLUSIONS -Previous studies have shown that fasting and postload glucose concentrations and BMI measured at the time of IGT recognition were the most consistent and strongest predictors of the progression from IGT to type 2 diabetes (17, 18) . We have shown that in our cohort of IGT subjects, plasma CRP level was also a useful predictor. Those IGT subjects with plasma CRP levels in the top two quartiles had approximately three times the risk of either remaining in IGT or progressing to diabetes compared with those individuals with plasma CRP in the lowest quartile. Previous studies have shown a graded increase in diabetes risk according to CRP quartiles or quintiles (3,4), but we did not find a graded increase in risk between the third and fourth quartiles of CRP in the present study. This is probably because of our relatively small sample size and the limited number of events. However, as shown in Table 4 , a much larger proportion of subjects in quartile 4 progressed to diabetes compared with quartile 3 (20 vs. 9%, respectively). The predictive power of CRP remained significant even after adjusting for anthropometric measures and lifestyle factors such as smoking, physical activity, and alcohol consumption. The strongest predictors of progression to diabetes in this study were 2-h glucose and plasma CRP levels. To identify individuals who would revert to NGT, 2-h glucose level and BMI were the most useful indicators. Most of the subjects who progressed from IGT to diabetes were in the top CRP quartile. They had increased waist-to-hip ra- The given odds ratio for continuous covariates is for an approximate 1-SD change.
tio, waist circumference, and plasma triglyceride level and fulfilled the criteria of the metabolic syndrome by WHO standards (16) . This is consistent with previous studies showing associations between inflammatory markers and features of the metabolic syndrome and suggests that chronic subclinical inflammation may play a role in the pathogenesis of disorders related to insulin resistance (6 -8) .
The conversion rate from IGT to diabetes in our study was 9.5% over 2 years or 4.8% per year. The yearly incidence of diabetes in our subjects with IGT was similar to that reported by epidemiological data (1.5-7.2%) (17) and the Finnish Study (6%) (19) , but lower than that reported in the Da Qing Study (15.7%) (20) and the STOP-Type 2 Diabetes Study (12.4%) (21) . It is well recognized that individuals with IGT can later revert to nondiabetic status and the significance of transient IGT may differ in different populations (22) . More than 50% of the IGT subjects in our study reverted to NGT at 2 years without intervention. This may be partly due to the variability in OGTT results accounted for by the phenomenon of regression to the mean (biological variability) (17) , awareness in the population examined, or factors known to impair glucose tolerance. None of our subjects were taking medications that could affect glucose tolerance, and no specific medical advice was given after the first OGTT. There is a need to refine our ability to identify subjects with IGT who will progress to type 2 diabetes because it is now possible to prevent diabetes in these high-risk subjects by lifestyle modification and/or pharmacological interventions (19 -21,23) . The validity of using CRP to improve our power to predict diabetes in the present study is limited by the short follow-up period and the small number of subjects progressing to diabetes at 2 years and will need to be confirmed by further prospective studies in the Chinese population.
In summary, we have shown that Chinese subjects with IGT have elevated plasma CRP levels and that CRP independently predicts the risk for either remaining in IGT or progressing to type 2 diabetes over a 2-year period. Plasma CRP level might provide an adjunctive measure for identifying subjects at highest risk for progression to diabetes, who, therefore, would derive the greatest benefits from preventive interventions.
